The ACR supports criteria development projects in different topic areas related to rheumatic disease.
Projects generally focus on classification, response, and remission criteria. The ACR has previously endorsed diagnostic criteria. This
article provides more detail on the differences between classification and diagnostic criteria, and why the ACR no longer endorses diagnostic criteria.
Below are a number of ACR-approved criteria sets. See information about the purpose of criteria sets, their development and validation, and the role of the ACR in adopting them. Also see the ACR Criteria Development Checklist.
2019 ACR Provisional Criteria for Clinically Relevant Improvement in Children and Adolescents with Childhood-Onset Systemic Lupus Erythematosus
2018 ACR Provisional Criteria for Global Flares in Childhood-Onset Systemic Lupus Erythematosus
2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
2017 EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
2016 ACR/EULAR Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis
2016 ACR/EULAR Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus
Early Diffuse Cutaneous Systemic Sclerosis
The ACR and EULAR consider Declarations of Interest for new collaborative projects in the following areas:
• Classification criteria
• Response criteria
The deadline to send submissions was May 10, 2021. Funding for projects will be available in July 2022.
See collaborative project details
The following criteria are in progress:
Learn more about what the ACR considers important when developing or endorsing criteria in the ACR Criteria Development Checklist.